In a recently published study, researchers from Brigham and Women’s Hospital have explored the impact of anxiety and depression on fertility and in vitro fertilization (IVF) outcomes in men
The findings reveal that there is no correlation between anxiety, including the use of antidepressants, and the success of IVF or live birth rates. This study provides valuable insights into the mental health considerations for individuals undergoing fertility treatments.
Study Methodology and Results
The study involved 222 men undergoing IVF at a hospital-affiliated fertility center between September 2018 and December 2022. Participants completed the Hospital Anxiety and Depression Scale (HADS) questionnaire, which assessed their levels of anxiety and depression. A score of eight or higher indicated the presence of anxiety or depression, respectively.
The results indicated that 22.5% of the respondents experienced anxiety, while 6.5% experienced depression based on their HADS scores. However, there was no significant difference in live birth rates between men with and without anxiety. Although men with anxiety had lower total motile sperm counts during egg retrieval, there was no impact on the overall IVF outcomes. The study also did not find any significant associations between antidepressant use and IVF outcomes or between anxiety and erectile dysfunction or low libido.
Implications and Future Research
The study’s findings challenge the concerns over the potential impact of antidepressant medication on fertility. The researchers suggest that anxiety medication should not be withheld from men experiencing anxiety or depression during IVF treatment. Stress, which is inherent in the IVF process, can itself affect fertility. Therefore, prioritizing patient mental health and addressing stress during fertility treatment is crucial.
The study had some limitations, including the inability to assess sperm morphology at the time of egg retrieval and evaluate the full impact of depression scores on fertility due to the small number of participants with high depression scores. Future research aims to investigate the impact of stress on hormone levels throughout the duration of fertility treatment. Screening patients for mental health issues before starting IVF treatment is also highlighted as important.
This study adds to the existing body of literature examining the relationship between mental health and male fertility outcomes
Based on the findings, patients are encouraged to pursue appropriate therapies for anxiety and depression without concerns about adverse effects on IVF outcomes.
Researchers emphasize the importance of considering mental health and stress management as integral parts of fertility treatment. By addressing these factors, healthcare providers can support patients better on their fertility journey.
